Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Kranz · SciRah

Researcher profile · Semantic Scholar

L. Kranz

Share profile

L. Kranz — researcher profile on SciRah

h-index: 19
Works: 45
Citations: 7,758

Most-cited papers

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
U. Şahin, A. Muik, E. Derhovanessian, I. Vogler +38 more
2020Nature1,611 citations Open access
Semantic Scholar
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
L. Kranz, M. Diken, H. Haas, S. Kreiter +24 more
2016Nature1,605 citations
Semantic Scholar
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
U. Şahin, P. Oehm, E. Derhovanessian, R. Jabulowsky +37 more
2020Nature903 citations
Semantic Scholar
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
U. Şahin, A. Muik, I. Vogler, E. Derhovanessian +45 more
2021Nature702 citations Open access
Semantic Scholar
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
Annette B. Vogel, Isis Kanevsky, Y. Che, K. Swanson +70 more
2021Nature646 citations Open access
Semantic Scholar
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
Katharina Reinhard, B. Rengstl, P. Oehm, K. Michel +19 more
2020Science452 citations
Semantic Scholar
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
C. Krienke, Laura Kolb, Elif Diken, M. Streuber +13 more
2021Science425 citations
Semantic Scholar
mRNA therapeutics in cancer immunotherapy
Jan D. Beck, Daniel A. Reidenbach, Nadja Salomon, U. Şahin +3 more
2021Molecular Cancer332 citations Open access
Semantic Scholar
Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening.
Alexandra G. Orlandini von Niessen, Marco A. Poleganov, C. Rechner, Arianne Plaschke +10 more
2019Molecular Therapy324 citations Open access
Semantic Scholar
BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans
U. Şahin, A. Muik, I. Vogler, E. Derhovanessian +45 more
2020medRxiv165 citations Open access
Semantic Scholar
A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates
Annette B. Vogel, Isis Kanevsky, Y. Che, K. Swanson +57 more
2020bioRxiv127 citations Open access
Semantic Scholar
Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma.
S. Grabbe, H. Haas, M. Diken, L. Kranz +2 more
2016Nanomedicine107 citations Open access
Semantic Scholar
Concurrent human antibody andTH1 type T-cell responses elicited by a COVID-19 RNA vaccine
U. Şahin, A. Muik, E. Derhovanessian, I. Vogler +38 more
2020medRxiv87 citations Open access
Semantic Scholar
mRNA: A Versatile Molecule for Cancer Vaccines.
M. Diken, L. Kranz, S. Kreiter, U. Şahin
2017Current Issues in Molecular Biology49 citations Open access
Semantic Scholar
mRNA Cancer Vaccines-Messages that Prevail.
C. Grunwitz, L. Kranz
2017Current Topics in Microbiology and Immunology40 citations
Semantic Scholar
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
U. Şahin, A. Muik, E. Derhovanessian, I. Vogler +38 more
2021Nature30 citations Open access
Semantic Scholar
Dexamethasone premedication suppresses vaccine-induced immune responses against cancer
Mathias Vormehr, Sophie M. Lehar, L. Kranz, S. Tähtinen +10 more
2020Oncoimmunology25 citations Open access
Semantic Scholar
BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2
Annette B. Vogel, Isis Kanevsky, Y. Che, K. Swanson +70 more
2020bioRxiv22 citations Open access
Semantic Scholar
An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation
A. Muik, I. Altıntaş, F. Gieseke, Kristina B Schoedel +17 more
2022Oncoimmunology20 citations Open access
Semantic Scholar
Merkel cell polyomavirus (MCV) T-antigen seroreactivity, MCV DNA in eyebrow hairs, and squamous cell carcinoma
S. Hampras, A. Michel, M. Schmitt, T. Waterboer +10 more
2015Infectious Agents and Cancer15 citations Open access
Semantic Scholar
Seroreactivity against Merkel cell polyomavirus and other polyomaviruses in chronic lymphocytic leukaemia, the MCC-Spain study.
C. Robles, D. Casabonne, Y. Benavente, L. Costas +14 more
2015Journal of General Virology13 citations Open access
Semantic Scholar
549 An RNA-lipoplex (RNA-LPX) vaccine demonstrates strong immunogenicity and promising clinical activity in a Phase I trial in cutaneous melanoma patients with no evidence of disease at trial inclusion
C. Loquai, J. Hassel, P. Brück, E. Derhovanessian +27 more
2021Journal for ImmunoTherapy of Cancer11 citations Open access
Semantic Scholar
Development and validation of HIV-1 Multiplex Serology.
L. Kranz, B. Gärtner, A. Michel, M. Pawlita +2 more
2019JIM - Journal of Immunological Methods10 citations
Semantic Scholar
Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma
R. Jabulowsky, C. Loquai, H. Mitzel-Rink, J. Utikal +33 more
2018Clinical Trials9 citations
Semantic Scholar
49PA first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for potent melanoma immunotherapy
L. Heesen, R. Jabulowsky, C. Loquai, J. Utikal +16 more
20179 citations Open access
Semantic Scholar
Abstract CT032: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent cancer immunotherapy in patients with malignant melanoma
R. Jabulowsky, C. Loquai, M. Diken, L. Kranz +28 more
20167 citations
Semantic Scholar
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
U. Şahin, P. Oehm, E. Derhovanessian, R. Jabulowsky +37 more
2020Nature6 citations
Semantic Scholar
Cross-competition shapes CD8+ T cell hierarchies and differentiation after RNA vaccination
Mark J. McCarron, Milena Hornburg, Thomas D. Wu, A. Tong +25 more
2025bioRxiv3 citations Open access
Semantic Scholar
RNA-encoded interleukin-2 with extended bioavailability amplifies RNA vaccine-induced antitumor T-cell immunity.
Daniel Peters, L. Kranz, D. Eisel, M. Diken +4 more
2024Cancer immunology research3 citations
Semantic Scholar
561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation
A. Muik, I. Altıntaş, Rachelle E. Kosoff, F. Gieseke +13 more
20203 citations Open access
Semantic Scholar
Abstract CT034: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent melanoma immunotherapy
R. Jabulowsky, C. Loquai, J. Utikal, J. Hassel +26 more
20173 citations
Semantic Scholar
Abstract B041: A novel nanoparticular formulated tetravalent RNA cancer vaccine for treatment of patients with malignant melanoma
R. Jabulowsky, C. Loquai, M. Diken, L. Kranz +28 more
20163 citations
Semantic Scholar
Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
U. Şahin, A. Muik, I. Vogler, E. Derhovanessian +45 more
2025Nature1 citations
Semantic Scholar
CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy
L. Kranz, M. Birtel, C. Krienke, C. Grunwitz +7 more
2015Human Vaccines & Immunotherapeutics1 citations Open access
Semantic Scholar
Opening Lecture: Oncology Meets Immunology the Advancing Targeted Therapies—report on the 11th Annual Meeting of the Association for Cancer Immunotherapy
M. Diken, S. Attig, C. Grunwitz, L. Kranz +4 more
1 citations
Semantic Scholar
Messenger RNA delivery of a dual CD25/CD122 affinity-tuned IL-2 variant prolongs exposure and potentiates antitumor T cell immunity
Mathias Vormehr, L. Kranz, A. Muik, S. Fellermeier-Kopf +7 more
2026Science Advances0 citations Open access
Semantic Scholar
mRNA therapeutics in cancer immunotherapy
Jan D. Beck, Daniel A. Reidenbach, Nadja Salomon, U. Şahin +3 more
2021Molecular Cancer0 citations Open access
Semantic Scholar
Abstract B62: Evaluation of systemic RNA-based cancer vaccine induced T-cell responses via mouse T-cell receptor (TCR) profiling
L. Kranz, Barbara Schrörs, Thomas Bukur, C. Albrecht +8 more
20200 citations
Semantic Scholar
CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy
L. Kranz, Jan D. Beck, C. Grunwitz, Christian Hotz +2 more
2017Human Vaccines & Immunotherapeutics0 citations Open access
Semantic Scholar
Abstract A004: Systemic RNA vaccines: Connecting effective cancer immunotherapy with antiviral defense mechanisms
L. Kranz, M. Diken, H. Haas, S. Kreiter +24 more
20160 citations
Semantic Scholar
CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany
L. Kranz, M. Birtel, Lina Hilscher, C. Grunwitz +6 more
2016Human Vaccines & Immunotherapeutics0 citations Open access
Semantic Scholar
Merkel cell polyomavirus (MCV) T-antigen seroreactivity, MCV DNA in eyebrow hairs, and squamous cell carcinoma
S. Hampras, A. Michel, M. Schmitt, T. Waterboer +10 more
2015Infectious Agents and Cancer0 citations Open access
Semantic Scholar
Lipid nanoparticles for organ-specific delivery of RNA
H. Haas, D. Fritz, M. Meng, L. Kranz +7 more
20140 citations
Semantic Scholar
CIMT 2014: Next waves in cancer immunotherapy - Report on the 12th annual meeting of the Association for Cancer Immunotherapy
M. Diken, Sebastian Boegel, C. Grunwitz, L. Kranz +5 more
2014Human Vaccines & Immunotherapeutics0 citations Open access
Semantic Scholar
Formulation d'arn pour l'immunothérapie
U. Şahin, Heinrich Haas, S. Kreiter, M. Diken +4 more
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

U. Şahin×34
Invite
U. Şahin — researcher profile on SciRah
O. Türeci×26
Invite
O. Türeci — researcher profile on SciRah
Mathias Vormehr×25
Invite
Mathias Vormehr — researcher profile on SciRah
M. Diken×24
Invite
M. Diken — researcher profile on SciRah

×18

Invite

S. Kreiter — researcher profile on SciRah

E. Derhovanessian×16

Invite

E. Derhovanessian — researcher profile on SciRah

Invite

A. Kuhn — researcher profile on SciRah

Invite

A. Muik — researcher profile on SciRah

Invite

H. Haas — researcher profile on SciRah

Invite

S. Attig — researcher profile on SciRah

Invite

D. Maurus — researcher profile on SciRah

U. Luxemburger×10

Invite

U. Luxemburger — researcher profile on SciRah